Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Zorica, I."'
Autor:
Matić Dragan M., Ašanin Milika R., Stanković Sanja Đ., Mrdović Igor B., Marinković Jelena M., Kočev Nikola I., Antonijević Nebojša M., Marjanović Marija M., Nešić Zorica I., Prostran Milica S., Stanković Goran R.
Publikováno v:
Vojnosanitetski Pregled, Vol 72, Iss 7, Pp 589-595 (2015)
Background/Aim. Data about bleeding complicating primary percutaneous coronary intervention (PCI) are more frequently obtained from randomized clinical trials on patients with acute coronary syndromes (ACS), but less frequently from surveys or reg
Externí odkaz:
https://doaj.org/article/7cd90d9318f74a57ac3f5f64ac55eae5
Publikováno v:
Vojnosanitetski Pregled, Vol 62, Iss 11, Pp 865-868 (2005)
Background. Hepatitis C virus (HCV) infection is the most frequent cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma in the world. Acute hepatitis C is the most commonly asymptomatic liver disease with the development of chronic HCV
Externí odkaz:
https://doaj.org/article/72ceaf888bcb43338a10e84b0dbc58b1
Autor:
Stojanović Radan M., Vasiljević Zorana, Prostran Milica Š., Radovanović Mina, Stefanović Branislav, Radovanović Nebojša, Janković Jelena, Lakičević Mirko, Mitrović Predrag, Lasica Ratko, Nešić Zorica I., Todorović Zoran, Stojanov Marina
Publikováno v:
Vojnosanitetski Pregled, Vol 62, Iss 9, Pp 661-670 (2005)
Externí odkaz:
https://doaj.org/article/985dd26e6c4b4751b51edc2ef8de9fe3
Autor:
Džoljić Eleonora, Nešić Zorica I., Stojanović Radan M., Divac Nevena, Todorović Zoran, Vučković Sonja M., Kostić Vladimir S., Prostran Milica Š.
Publikováno v:
Vojnosanitetski Pregled, Vol 62, Iss 10, Pp 751-756 (2005)
Externí odkaz:
https://doaj.org/article/079919e141a84e5696fe133a4a98d173
Autor:
Vučković Sonja M., Prostran Milica Š., Ivanović Milovan D., Todorović Zoran M., Stojanović Radan M., Nešić Zorica I., Matić Ivana, Milovanović Slobodan R.
Publikováno v:
Vojnosanitetski Pregled, Vol 61, Iss 4, Pp 413-421 (2004)
Externí odkaz:
https://doaj.org/article/93c29f54057f41c48822c3ab1d283bcb
Autor:
Stojanović Radan M., Prostran Milica Š., Todorović Zoran M., Vučković Sonja M., Nešić Zorica I., Milovanović Slobodan R.
Publikováno v:
Vojnosanitetski Pregled, Vol 61, Iss 3, Pp 299-304 (2004)
Externí odkaz:
https://doaj.org/article/e0e9969627244d2392f5771c17916b6a
Autor:
Dusanka, Tadic, Slavica, Djukic Dejanovic, Zorica I Tomasevic Danijela, Djokovic, Vladimir, Janjic
Publikováno v:
Journal of B.U.ON. : official journal of the Balkan Union of Oncology. 25(1)
This study was conducted to assess the impact of structured education of breast cancer patients receiving capecitabine treatment on depression, anxiety and stress.The study included 142 breast cancer patients who were receiving capecitabine at the In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5abd3339d079035adafcb309870249f1
https://pubmed.ncbi.nlm.nih.gov/32277625
https://pubmed.ncbi.nlm.nih.gov/32277625
Autor:
Tadić Dušanka, Djukić-Dejanović Slavica, Tomašević Zorica I, Đoković Danijela, Janjić Vladimir
Purpose: This study was conducted to assess the impact of structured education of breast cancer patients receiving capecitabine treatment on depression, anxiety and stress. Methods: The study included 142 breast cancer patients who were receiving cap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d394141474ecbba6e8d175d39fbab93
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 165-167 (2003)
For almost 40 years, the only option for patients with unresectable metastases was treatment with 5-fluorouracil. In the last decade, new drugs became available that changed attitude toward treatment of metastatic CRC as well as the prognosis for som
Externí odkaz:
https://doaj.org/article/2e53572fd5de42ba9cae4b32bd068958
Publikováno v:
Archive of Oncology, Vol 11, Iss 3, Pp 157-159 (2003)
Gastric carcinoma is a frequent malignancy throughout the world and endemic in many of its regions. Advanced gastric carcinoma is often diagnosed. Patients with advanced gastric cancer have a median survival of 6-8 months and chemotherapy is palliati
Externí odkaz:
https://doaj.org/article/df7c3cc5a0cd41c295c85cd19e1e2ea5